NDC 57894-502 – Darzalex
Daratumumab 100 mg/5mL · Injection, Solution, Concentrate · Intravenous
Product NDC57894-502
Product details
- Brand name
- Darzalex
- Generic name
- Daratumumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761036
- Marketed since
- November 16, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD38-directed Cytolytic Antibody
Active ingredients
- Daratumumab 100 mg/5mL
Package NDC codes (0)
| Package NDC | Description | Since |
|---|